Mitsubishi creates new technology to control in-building mobile robots
Category: #tech  By Pankaj Singh  Date: 2020-02-05
  • share
  • Twitter
  • Facebook
  • LinkedIn

Mitsubishi creates new technology to control in-building mobile robots

Mitsubishi Electric Corporation has recently announced its technological development to control in-building mobile robots, by using building dynamic maps. This new 3D building map will show the status of mobilities within the building, including their interactions with elevators and access control systems, location, and passable routes. The in-building mobile robots find application in cleaning, delivery, security, guidance, as well as next-gen electric wheelchairs.

The electronics and electrical equipment manufacturing company’s newly introduced technology can help connect these robots to the building’s systems for safe and efficient movement of people and In-building Mobilities. This technology is expected to help realize the vision of a smart building where advanced IoT is deployed, allowing people and robots to coexist in harmony to form labor- and energy-saving work environments.

A major task performed by the company’s newly developed In-building Mobilities technology is the efficient control of mobilities’ movement inside the building to avoid collisions. The system automatically guides the mobilities through elevators, narrow aisles, and prevents them from entering prohibited areas or crowded elevators. The system uses the map while crossing an access-control gate to prioritize the movement of people and avoid accidents. Access-control systems and elevators are directly linked together for safe and efficient movement of In-building Mobilities within the building.

Additionally, the system can help reduce building management workloads. For instance, in case a mobility device breaks down, the new technology will record the operations of the elevator and other mobilities to locate each unit on the building dynamic map.

For the efficient workflow of the system, animated lighting is displayed on the building floors when the mobilities board or alight the elevator. This will allow people to anticipate the movements of mobilities getting on and off the elevators, for smooth and safe entry or exit from the elevators. The animated lighting also indicates the movement of In-building Mobilities in other building spaces to avoid collision, including narrow pathways or during poor visibility conditions.

Source credit:

https://www.mitsubishielectric.com/news/2020/0204-a.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

Toyota and ENEOS team up to develop hydrogen fuel-cell system in Japan
Toyota and ENEOS team up to develop hydrogen fuel-cell system in Japan
By Pankaj Singh

Japanese automotive giant, Toyota has reportedly tapped Japanese oil & energy corporation, ENEOS, to explore the field of hydrogen-based power to help with the development of a hydrogen fuel-cell system that would power Woven City, Japan’s ...

KPI Global secures 12.5 MW captive solar project from Anupam Rasayan
KPI Global secures 12.5 MW captive solar project from Anupam Rasayan
By Pankaj Singh

Gujarats leading solar power generating company, KPI Global, has recently announced receiving an order for building a 12.5 megawatts solar project under the captive power producer capacity from Surat-headquartered Anupam Rasayan India. It has been r...

Adverum Biotechnologies announces new data from OPTIC Phase 1 trial
Adverum Biotechnologies announces new data from OPTIC Phase 1 trial
By Pankaj Singh

Adverum Biotechnologies, a California based biotech company, has reportedly announced new clinical data from the OPTIC Phase 1 with dose ranging clinical stage trial of gene therapy intravitreal injection namely ADVM-022. The OPTIC trial has enrolle...